Abstract

DW Bartlett, C Friedrich, M Reed, R Baillie

Application of a physiologically based model incorporating drug-specific PK modules to support optimization of GLP-1 receptor agonist combination therapies for type 2 diabetes

Presented by Rosa at the American Association of Pharmaceutical Scientists (AAPS), 2013

Poster

E Hussey, J Cote-Sierra, H Hofland, V Damian-lordache, T Wilde, W Chern, C Friedrich, R Baillie

Physiological model to investigate and prioritize targets for psoriasis

Presented by Stiefel and Rosa at American Conference on Pharmacometrics (ACoP), 2013, and at American Association of Pharmaceutical Scientists (AAPS) 2013

Abstract

E Kang, T Wilde, V Damian-lordache, E Hussey, C Friedrich, R Baillie, W Chern

Mechanistic and quantitative physiological models for the evaluation and prioritization of dermatology disease targets

Presented by Stiefel and Rosa at American Society for Clinical Pharmacology and Therapeutics (ASCPT), 2013

Abstract

C Friedrich, R Baillie

Virtual Combination Therapy in Virtual NSCLC Tumor Cells Supports Strategic Development and Treatment Decisions

Presented by Rosa at the Keystone Symposia, Cancer and Metabolism, 2013

Oral Presentation

R Baillie, C Friedrich, M Reed

Using Formal Qualitative Modeling in Drug Development

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), 2013

Oral Presentation

MJ Reed

Application of Mechanistic Physiological Modeling in the Drug Development Process – Overview and Case Studies

Presented by Rosa at the 28th Japanese Society for the Study of Xenobiotics (JSSX) Annual Meeting on Drug Metabolism and Pharmacokinetics, 2013

Oral Presentation

R Beaver

Accomplishments and Challenges in Systems Pharmacology

Presented by Rosa at the Hanson Wade Integrating Pharmacometrics Summit, 2013

Oral Presentation

T Gordi

Models and Their Utility in the Drug Development Process

Presented by Rosa at the American Association of Pharmaceutical Scientists (AAPS) Bay Area Development Group (BADG), 2013

"I am grateful to our many clients who have challenged us over the past 17 years to conduct PhysioPD Research on the frontier of science."
—Ron Beaver, PhD, Founder, CEO
Learn more about PhysioPD